Major Stakeholder Offloads Shares in Bio Green Med Solution!

New insider activity at Bio Green Med Solution ( (BGMS) ) has taken place on October 22, 2025.

Significant shareholder FITTERS Diversified Berhad has sold 108,107 shares of Bio Green Med Solution stock, amounting to a transaction worth $332,969.

Recent Updates on BGMS stock

Bio Green Med Solution (BGMS) has recently undergone significant developments, including finalizing an Asset Purchase Agreement with Tethra Biosciences Inc. to sell certain assets, including patent rights related to Plogosertib, for $300,000 with a potential milestone payment of $170,000. This transaction represents a strategic shift in the company’s operations, potentially affecting its market positioning. Additionally, BGMS announced a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock, payable on November 1, 2025. Despite these developments, Spark, TipRanks’ AI Analyst, maintains a ‘Underperform’ rating on BGMS, citing the company’s financial strain, operational inefficiencies, and unattractive valuation due to a negative P/E ratio and lack of dividend yield. The technical sentiment signal remains a ‘Strong Sell.’

Spark’s Take on BGMS Stock

According to Spark, TipRanks’ AI Analyst, BGMS is a Underperform.

Cyclacel Pharmaceuticals is currently under significant financial strain, marked by operational inefficiencies and a weak financial position, as reflected in its low financial performance score. While the technical indicators suggest a neutral trend, the valuation is unattractive due to its negative P/E ratio and lack of dividend yield. These factors collectively result in a low overall stock score.

To see Spark’s full report on BGMS stock, click here.

More about Bio Green Med Solution

YTD Price Performance: -96.81%

Average Trading Volume: 444,667

Technical Sentiment Signal: Strong Sell

Current Market Cap: $6.65M